img

#1

US IPO Issuance in 2022 - 2024 YTD3

img

#1

SPAC issuance in 2022 - 2024 YTD2

img

$23B+

in Gross Proceeds Raised3

img

300+

Transactions Completed3

Recent Transactions
June 23, 2023
img
img
SMX (Security Matters) Public Limited Company
(Nasdaq: SMX)

$3,200,000

Underwritten Public Offering
Sole Bookrunner

June 16, 2023
img
img
Bone Biologics Corporation
(Nasdaq: BBLG)

$5,000,000

Underwritten Public Offering
Sole Bookrunner

June 16, 2023
img
img
Clene Inc.
(Nasdaq: CLNN)

$40,000,000

Underwritten Public Offering
Co-Manager

May 24, 2023
img
img
Biocept, Inc.
(Nasdaq: BIOC)

$4,999,998

Underwritten Public Offering
Sole Bookrunner

May 19, 2023
img
img
Bright Green Corporation
(Nasdaq: BGXX)

$3,500,000

Private Placement
Exclusive Placement Agent

May 15, 2023
img
img
Guardforce AI Co., Limited
(Nasdaq: GFAI)

$13,799,759

Underwritten Public Offering
Sole Bookrunner

May 5, 2023
img
img
Guardforce AI Co., Limited
(Nasdaq: GFAI)

$9,199,997

Underwritten Public Offering
Sole Bookrunner

April 25, 2023
img
img
Sidus Space, Inc.
(Nasdaq: SIDU)

$11,248,025

Underwritten Public Offering
Joint Bookrunner

April 20, 2023
img
img
Enovix Corporation
(Nasdaq: ENVX)

$140,000,000

Convertible Senior Notes
Co-Manager

April 13, 2023
img
img
AERWINS Technologies Inc.
(Nasdaq: AWIN)

$5,000,000

Private Placement
Exclusive Placement Agent

April 3, 2023
img
img
Chanson International Holding
(Nasdaq: CHSN)

$13,560,000

Initial Public Offering
Sole Bookrunner

March 31, 2023
img
img
Hongli Group Inc.
(Nasdaq: HLP)

$8,250,000

Initial Public Offering
Sole Bookrunner

1 … 8 9 10 11 12 … 34
Insights
  • April 9, 2025

    D. Boral Capital Acted as Sole Bookrunner to FatPipe, Inc. (Nasdaq: FATN) in connection with its $4.0 Million Initial Public Offering

    Read More icon Read More icon
  • March 27, 2025

    D. Boral Capital Acted as Sole Bookrunner to Epsium Enterprise Limited (Nasdaq: EPSM) in connection with its $5.0 Million Initial Public Offering

    Read More icon Read More icon
  • March 26, 2025

    D. Boral Capital Acted as Exclusive Placement Agent to Inspire Veterinary Partners, Inc. (Nasdaq: IVP) in connection with its up to $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

    Read More icon Read More icon
  • March 4, 2025

    D. Boral Capital Served as Exclusive Placement Agent to Plus Therapeutics, Inc. (Nasdaq: PSTV) in connection with its up to $15.0 Million Private Placement

    Read More icon Read More icon
img
View All

Together, let's build meaningful value.